{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T20:39:39Z","timestamp":1793392779123,"version":"4.5.0"},"reference-count":69,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,12,7]],"date-time":"2023-12-07T00:00:00Z","timestamp":1701907200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,12,7]],"date-time":"2023-12-07T00:00:00Z","timestamp":1701907200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001411","name":"Indian Council of Medical Research","doi-asserted-by":"publisher","award":["3\/1\/2(5)CD\/2021-NCD-II"],"award-info":[{"award-number":["3\/1\/2(5)CD\/2021-NCD-II"]}],"id":[{"id":"10.13039\/501100001411","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The current piece of research intends to evaluate the potential of combining etodolac with deformable-emulsomes, a flexible vesicular system, as a promising strategy for the topical therapy of arthritis. The developed carrier system featured nanometric dimensions (102\u00a0nm), an improved zeta potential (\u2212\u00a05.05\u00a0mV), sustained drug release (31.33%), and enhanced drug deposition (33.13%) of DE-gel vis-\u00e0-vis conventional system (10.34% and 14.71%). The amount of permeation of the developed nano formulation across skin layers was demonstrated through CLSM and dermatokinetics studies. The safety profile of deformable-emulsomes has been investigated through in vitro HaCaT cell culture studies and skin compliance studies. The efficacy of the DE-gel formulation was sevenfold higher in case of Xylene induced ear edema model and 2.2-folds in CFA induced arthritis model than that of group treated with conventional gel (p\u2009&lt;\u20090.01). The main technological rationale lies in the use of phospholipid and sodium deoxycholate-based nanoscale flexible lipoidal vesicles, which effectively encapsulate drug molecules within their interiors. This encapsulation enhances the molecular interactions and facilitates the transportation of the drug molecule effectively to the target-site. Hence, these findings offer robust scientific evidence to support additional investigation into the potential utility of flexible vesicular systems as a promising drug delivery alternative for molecules of this nature.<\/jats:p>","DOI":"10.1038\/s41598-023-46119-7","type":"journal-article","created":{"date-parts":[[2023,12,8]],"date-time":"2023-12-08T10:03:44Z","timestamp":1702029824000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Exploring the therapeutic potential of sodium deoxycholate tailored deformable-emulsomes of etodolac for effective management of arthritis"],"prefix":"10.1038","volume":"13","author":[{"given":"Gajanand","family":"Sharma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akanksha","family":"Mahajan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kanika","family":"Thakur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gurjeet","family":"Kaur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vijay G.","family":"Goni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muniramiah Vinod","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ravi Pratap","family":"Barnwal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gurpal","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bhupinder","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O. P.","family":"Katare","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,12,7]]},"reference":[{"issue":"Suppl 3","key":"46119_CR1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/ar4173","volume":"15","author":"LJ Crofford","year":"2013","unstructured":"Crofford, L. J. Use of NSAIDs in treating patients with arthritis. Arthritis Res. Ther. 15(Suppl 3), 1\u201310 (2013).","journal-title":"Arthritis Res. Ther."},{"key":"46119_CR2","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1615\/CritRevTherDrugCarrierSyst.v27.i6.20","volume":"27","author":"KM Manjanna","year":"2010","unstructured":"Manjanna, K. M., Shivakumar, B. & Pramod Kumar, T. M. Microencapsulation: An acclaimed novel drug-delivery system for NSAIDs in arthritis. Crit. Rev. Ther. Drug Carrier Syst. 27, 509\u2013545 (2010).","journal-title":"Crit. Rev. Ther. Drug Carrier Syst."},{"key":"46119_CR3","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1007\/BF02668029","volume":"3","author":"KB Glaser","year":"1995","unstructured":"Glaser, K. B. Cyclooxygenase selectivity and NSAIDs: Cyclooxygenase-2 selectivity of etodolac (LODINE). Inflammopharmacology 3, 335\u2013345 (1995).","journal-title":"Inflammopharmacology"},{"key":"46119_CR4","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1159\/000069536","volume":"68","author":"M Tachibana","year":"2003","unstructured":"Tachibana, M. et al. Anti-inflammatory effect and low ulcerogenic activity of etodolac, a cyclooxygenase-2 selective non-steroidal anti-inflammatory drug, on adjuvant-induced arthritis in rats. Pharmacology 68, 96\u2013104 (2003).","journal-title":"Pharmacology"},{"key":"46119_CR5","doi-asserted-by":"publisher","first-page":"393","DOI":"10.2147\/TCRM.S24458","volume":"7","author":"CE Argoff","year":"2011","unstructured":"Argoff, C. E. & Gloth, F. M. Topical nonsteroidal anti-inflammatory drugs for management of osteoarthritis in long-term care patients. Ther. Clin. Risk Manag. 7, 393\u2013399 (2011).","journal-title":"Ther. Clin. Risk Manag."},{"key":"46119_CR6","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1007\/s10787-997-0023-8","volume":"5","author":"N Bellamy","year":"1997","unstructured":"Bellamy, N. Etodolac in the management of pain: A clinical review of a multipurpose analgesic. Inflammopharmacology 5, 139\u2013152 (1997).","journal-title":"Inflammopharmacology"},{"key":"46119_CR7","first-page":"23","volume":"47","author":"TJ Schnitzer","year":"1997","unstructured":"Schnitzer, T. J. & Constantine, G. Etodolac (Lodine) in the treatment of osteoarthritis: Recent studies. J. Rheumatol. Suppl. 47, 23\u201331 (1997).","journal-title":"J. Rheumatol. Suppl."},{"key":"46119_CR8","unstructured":"IPC. Etodolac. The Indian Pharmacopoeia Commission 2, 1318\u20131319, (2010)."},{"key":"46119_CR9","unstructured":"BP. British Pharmacopoeia British Pharmacopoeia Commission I, 864\u2013866, (2008)."},{"key":"46119_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/med.2610070102","volume":"7","author":"LG Humber","year":"1987","unstructured":"Humber, L. G. Etodolac: The chemistry, pharmacology, metabolic disposition, and clinical profile of a novel anti-inflammatory pyranocarboxylic acid. Med. Res. Rev. 7, 1\u201328 (1987).","journal-title":"Med. Res. Rev."},{"key":"46119_CR11","doi-asserted-by":"publisher","first-page":"2106","DOI":"10.1016\/S0140-6736(99)02332-6","volume":"354","author":"P Emery","year":"1999","unstructured":"Emery, P. et al. Celecoxib versus diclofenac in long-term management of rheumatoid arthritis: Randomised double-blind comparison. Lancet 354, 2106\u20132111 (1999).","journal-title":"Lancet"},{"key":"46119_CR12","first-page":"1061","volume":"11","author":"N Moore","year":"2015","unstructured":"Moore, N., Pollack, C. & Butkerait, P. Adverse drug reactions and drug-drug interactions with over-the-counter NSAIDs. Ther. Clin. Risk Manag. 11, 1061\u20131075 (2015).","journal-title":"Ther. Clin. Risk Manag."},{"key":"46119_CR13","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1080\/10717540701603746","volume":"14","author":"C Tas","year":"2007","unstructured":"Tas, C., Ozkan, Y., Okyar, A. & Savaser, A. In vitro and ex vivo permeation studies of etodolac from hydrophilic gels and effect of terpenes as enhancers. Drug Deliv. 14, 453\u2013459 (2007).","journal-title":"Drug Deliv."},{"key":"46119_CR14","doi-asserted-by":"publisher","first-page":"9324567","DOI":"10.1155\/2016\/9324567","volume":"2016","author":"G Shilakari Asthana","year":"2016","unstructured":"Shilakari Asthana, G., Asthana, A., Singh, D. & Sharma, P. K. Etodolac containing topical niosomal gel: Formulation development and evaluation. J. Drug Deliv. 2016, 9324567 (2016).","journal-title":"J. Drug Deliv."},{"key":"46119_CR15","unstructured":"David, A. O. & Anton, H. A. Topical Drug Delivery Formulations., 1 (Marcel Dekker, 1990)."},{"key":"46119_CR16","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/s40824-021-00226-6","volume":"25","author":"WY Jeong","year":"2021","unstructured":"Jeong, W. Y., Kwon, M., Choi, H. E. & Kim, K. S. Recent advances in transdermal drug delivery systems: A review. Biomater. Res. 25, 24 (2021).","journal-title":"Biomater. Res."},{"key":"46119_CR17","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1007\/s40199-018-0214-4","volume":"26","author":"N Madhavi","year":"2018","unstructured":"Madhavi, N., Sudhakar, B., Suresh Reddy, K. V. N. & Vijaya Ratna, J. Pharmacokinetic and pharmacodynamic studies of etodolac loaded vesicular gels on rats by transdermal delivery. Daru J. Pharm. Sci. 26, 43\u201356 (2018).","journal-title":"Daru J. Pharm. Sci."},{"key":"46119_CR18","doi-asserted-by":"publisher","first-page":"101810","DOI":"10.1016\/j.bcab.2020.101810","volume":"29","author":"DK Patel","year":"2020","unstructured":"Patel, D. K., Kesharwani, R. & Kumar, V. Etodolac loaded solid lipid nanoparticle based topical gel for enhanced skin delivery. Biocataly. Agric. Biotechnol. 29, 101810 (2020).","journal-title":"Biocataly. Agric. Biotechnol."},{"key":"46119_CR19","doi-asserted-by":"publisher","first-page":"235","DOI":"10.3390\/molecules28010235","volume":"28","author":"A Czajkowska-Ko\u015bnik","year":"2022","unstructured":"Czajkowska-Ko\u015bnik, A., Szyma\u0144ska, E. & Winnicka, K. Nanostructured lipid carriers (NLC)-based gel formulations as Etodolac delivery: From gel preparation to permeation study. Molecules (Basel, Switzerland) 28, 235 (2022).","journal-title":"Molecules (Basel, Switzerland)"},{"key":"46119_CR20","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1080\/10717544.2017.1326539","volume":"24","author":"S Salah","year":"2017","unstructured":"Salah, S., Mahmoud, A. A. & Kamel, A. O. Etodolac transdermal cubosomes for the treatment of rheumatoid arthritis: Ex vivo permeation and in vivo pharmacokinetic studies. Drug Deliv. 24, 846\u2013856 (2017).","journal-title":"Drug Deliv."},{"key":"46119_CR21","first-page":"926","volume":"12","author":"ZA Sadeq","year":"2020","unstructured":"Sadeq, Z. A., Ghazy, E. & Salim, Z. Etodolac topical spray films, development, characterization and in-vitro evaluation. Int. J. Pharm. Res. 12, 926\u2013931 (2020).","journal-title":"Int. J. Pharm. Res."},{"key":"46119_CR22","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1080\/03639045.2019.1569030","volume":"45","author":"N Madhavi","year":"2019","unstructured":"Madhavi, N., Sudhakar, B., Reddy, K. & Ratna, J. V. Design by optimization and comparative evaluation of vesicular gels of etodolac for transdermal delivery. Drug Dev. Ind. Pharm. 45, 611\u2013628 (2019).","journal-title":"Drug Dev. Ind. Pharm."},{"key":"46119_CR23","unstructured":"Kollapali, R., Akondi, V. & Beeravelli, S. Statistical Optimization of Etodolac Loaded Transfersomes for Effective Pain Relief through Skin. (2013)."},{"key":"46119_CR24","doi-asserted-by":"crossref","first-page":"64","DOI":"10.31351\/vol28iss1pp64-74","volume":"28","author":"MA Maysam","year":"2019","unstructured":"Maysam, M. A. & Nawal, A. R. Preparation and characterization of etodolac as a topical nanosponges hydrogel. Iraqi J. Pharm. Sci. 28, 64\u201374 (2019).","journal-title":"Iraqi J. Pharm. Sci."},{"key":"46119_CR25","doi-asserted-by":"publisher","first-page":"3049","DOI":"10.5958\/0974-360X.2017.00541.8","volume":"10","author":"SB Gondkar","year":"2017","unstructured":"Gondkar, S. B., Patil, N. & Saudagar, R. Formulation development and characterization of etodolac loaded transethosomes for transdermal delivery. Res. J. Pharm. Technol. 10, 3049\u20133057 (2017).","journal-title":"Res. J. Pharm. Technol."},{"key":"46119_CR26","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1080\/02652048.2021.1895344","volume":"38","author":"A Karakucuk","year":"2021","unstructured":"Karakucuk, A., Tort, S., Han, S., Oktay, A. N. & Celebi, N. Etodolac nanosuspension based gel for enhanced dermal delivery: In vitro and in vivo evaluation. J. Microencapsul. 38, 218\u2013232 (2021).","journal-title":"J. Microencapsul."},{"key":"46119_CR27","doi-asserted-by":"publisher","first-page":"567","DOI":"10.3390\/nano13030567","volume":"13","author":"J Xie","year":"2023","unstructured":"Xie, J., Lee, K., Park, H., Jung, H. & Oh, J. M. Enhanced emulsifying ability of deoxycholate through dynamic interaction with layered double hydroxide. Nanomaterials (Basel, Switzerland) 13, 567 (2023).","journal-title":"Nanomaterials (Basel, Switzerland)"},{"key":"46119_CR28","doi-asserted-by":"publisher","first-page":"3177","DOI":"10.2147\/IJN.S188842","volume":"14","author":"H Song","year":"2019","unstructured":"Song, H. et al. Enhanced transdermal permeability and drug deposition of rheumatoid arthritis via sinomenine hydrochloride-loaded antioxidant surface transethosome. Int. J. Nanomed. 14, 3177\u20133188 (2019).","journal-title":"Int. J. Nanomed."},{"key":"46119_CR29","doi-asserted-by":"publisher","first-page":"644","DOI":"10.3390\/pharmaceutics11120644","volume":"11","author":"R Molinaro","year":"2019","unstructured":"Molinaro, R. et al. Development and in vivo evaluation of multidrug ultradeformable vesicles for the treatment of skin inflammation. Pharmaceutics 11, 644 (2019).","journal-title":"Pharmaceutics"},{"key":"46119_CR30","first-page":"6","volume-title":"QbD and Product Performance Focus Group Newsletter","author":"K Raza","year":"2014","unstructured":"Raza, K., Katare, O. P. & Singh, B. QbD and Product Performance Focus Group Newsletter 6\u201311 (AAPS, 2014)."},{"key":"46119_CR31","doi-asserted-by":"publisher","first-page":"2959","DOI":"10.3390\/molecules25132959","volume":"25","author":"H Natsheh","year":"2020","unstructured":"Natsheh, H. & Touitou, E. Phospholipid vesicles for dermal\/transdermal and nasal administration of active molecules: The effect of surfactants and alcohols on the fluidity of their lipid bilayers and penetration enhancement properties. Molecules (Basel, Switzerland) 25, 2959 (2020).","journal-title":"Molecules (Basel, Switzerland)"},{"key":"46119_CR32","doi-asserted-by":"publisher","first-page":"228","DOI":"10.3109\/08982100903347923","volume":"20","author":"C Jaafar-Maalej","year":"2010","unstructured":"Jaafar-Maalej, C., Diab, R., Andrieu, V., Elaissari, A. & Fessi, H. Ethanol injection method for hydrophilic and lipophilic drug-loaded liposome preparation. J. Liposome Res. 20, 228\u2013243 (2010).","journal-title":"J. Liposome Res."},{"key":"46119_CR33","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1081\/LPR-100103174","volume":"11","author":"Y Maitani","year":"2001","unstructured":"Maitani, Y., Soeda, H., Junping, W. & Takayama, K. Modified ethanol injection method for liposomes containing beta-sitosterol beta-D-glucoside. J. Liposome Res. 11, 115\u2013125 (2001).","journal-title":"J. Liposome Res."},{"key":"46119_CR34","doi-asserted-by":"publisher","first-page":"102174","DOI":"10.1016\/j.jddst.2020.102174","volume":"61","author":"A Gouda","year":"2021","unstructured":"Gouda, A., Sakr, O. S., Nasr, M. & Sammour, O. Ethanol injection technique for liposomes formulation: An insight into development, influencing factors, challenges and applications. J. Drug Deliv. Sci. Technol. 61, 102174 (2021).","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"46119_CR35","first-page":"1","volume":"10","author":"G Sharma","year":"2016","unstructured":"Sharma, G., Goyal, H., Thakur, K., Raza, K. & Katare, O. P. Novel elastic membrane vesicles (EMVs) and ethosomes-mediated effective topical delivery of aceclofenac: A new therapeutic approach for pain and inflammation. Drug Deliv. 10, 1\u201311 (2016).","journal-title":"Drug Deliv."},{"key":"46119_CR36","doi-asserted-by":"publisher","first-page":"110902","DOI":"10.1016\/j.colsurfb.2020.110902","volume":"190","author":"P Nirbhavane","year":"2020","unstructured":"Nirbhavane, P. et al. Triamcinolone acetonide loaded-cationic nano-lipoidal formulation for uveitis: Evidences of improved biopharmaceutical performance and anti-inflammatory activity. Colloids Surf. B Biointerfaces 190, 110902 (2020).","journal-title":"Colloids Surf. B Biointerfaces"},{"key":"46119_CR37","doi-asserted-by":"publisher","first-page":"1800501","DOI":"10.1002\/ejlt.201800501","volume":"121","author":"AR Kim","year":"2019","unstructured":"Kim, A. R. et al. Preparation, physical characterization, and in vitro skin permeation of deformable liposomes loaded with taxifolin and taxifolin tetraoctanoate. Eur. J. Lipid Sci. Tech. 121, 1800501 (2019).","journal-title":"Eur. J. Lipid Sci. Tech."},{"key":"46119_CR38","doi-asserted-by":"publisher","first-page":"118833","DOI":"10.1016\/j.memsci.2020.118833","volume":"620","author":"Y Yang","year":"2021","unstructured":"Yang, Y., Li, Y., Goh, K., Tan, C. H. & Wang, R. Liposomes-assisted fabrication of high performance thin film composite nanofiltration membrane. J. Membr. Sci. 620, 118833 (2021).","journal-title":"J. Membr. Sci."},{"key":"46119_CR39","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.ijpharm.2012.04.036","volume":"430","author":"A Chaudhury","year":"2012","unstructured":"Chaudhury, A. et al. Lyophilization of cholesterol-free PEGylated liposomes and its impact on drug loading by passive equilibration. Int. J. Pharm. 430, 167\u2013175 (2012).","journal-title":"Int. J. Pharm."},{"key":"46119_CR40","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1007\/s13346-017-0364-9","volume":"8","author":"G Sharma","year":"2018","unstructured":"Sharma, G., Devi, N., Thakur, K., Jain, A. & Katare, O. P. Lanolin-based organogel of salicylic acid: Evidences of better dermatokinetic profile in imiquimod-induced keratolytic therapy in BALB\/c mice model. Drug Deliv. Transl. Res. 8, 398\u2013413 (2018).","journal-title":"Drug Deliv. Transl. Res."},{"key":"46119_CR41","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.ejps.2005.01.021","volume":"25","author":"KL Yap","year":"2005","unstructured":"Yap, K. L., Liu, X., Thenmozhiyal, J. C. & Ho, P. C. Characterization of the 13-cis-retinoic acid\/cyclodextrin inclusion complexes by phase solubility, photostability, physicochemical and computational analysis. Eur. J. Pharm. Sci. 25, 49\u201356 (2005).","journal-title":"Eur. J. Pharm. Sci."},{"key":"46119_CR42","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1080\/17425247.2020.1723545","volume":"17","author":"M Sharma","year":"2020","unstructured":"Sharma, M. et al. Holistic development of coal tar lotion by embedding design of experiments (DoE) technique: Preclinical investigations. Expert Opin. Drug Deliv. 17, 255\u2013273 (2020).","journal-title":"Expert Opin. Drug Deliv."},{"key":"46119_CR43","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1080\/17425247.2021.1919618","volume":"18","author":"G Sharma","year":"2021","unstructured":"Sharma, G. et al. Co-delivery of isotretinoin and clindamycin by phospholipid-based mixed micellar system confers synergistic effect for treatment of acne vulgaris. Expert Opin. Drug Deliv. 18, 1291\u20131308 (2021).","journal-title":"Expert Opin. Drug Deliv."},{"key":"46119_CR44","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1111\/j.1473-2165.2009.00468.x","volume":"8","author":"A Bhatia","year":"2009","unstructured":"Bhatia, A., Raza, K., Singh, B. & Katare, O. P. Phospholipid-based formulation with improved attributes of coal tar. J. Cosmet. Dermatol. 8, 282\u2013288 (2009).","journal-title":"J. Cosmet. Dermatol."},{"key":"46119_CR45","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1166\/jnd.2014.1036","volume":"2","author":"P Negi","year":"2014","unstructured":"Negi, P., Singh, B., Sharma, G. & Katare, O. P. Enhanced topical delivery of lidocaine via ethosomes-based hydrogel: Ex-vivo and in-vivo evaluation. J. Nanopharm. Drug Deliv. 2, 1\u201310 (2014).","journal-title":"J. Nanopharm. Drug Deliv."},{"key":"46119_CR46","first-page":"1","volume":"21","author":"P Negi","year":"2015","unstructured":"Negi, P. et al. Phospholipid microemulsion-based hydrogel for enhanced topical delivery of lidocaine and prilocaine: QbD-based development and evaluation. Drug Deliv. 21, 1\u201317 (2015).","journal-title":"Drug Deliv."},{"key":"46119_CR47","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.3109\/10717544.2015.1110845","volume":"23","author":"S Wadhwa","year":"2016","unstructured":"Wadhwa, S., Singh, B., Sharma, G., Raza, K. & Katare, O. P. Liposomal fusidic acid as a potential delivery system: A new paradigm in the treatment of chronic plaque psoriasis. Drug Deliv. 23, 1204\u20131213 (2016).","journal-title":"Drug Deliv."},{"key":"46119_CR48","doi-asserted-by":"publisher","first-page":"943","DOI":"10.3109\/1061186X.2015.1048518","volume":"23","author":"T Chhibber","year":"2015","unstructured":"Chhibber, T., Wadhwa, S., Chadha, P., Sharma, G. & Katare, O. P. Phospholipid structured microemulsion as effective carrier system with potential in methicillin sensitive Staphylococcus aureus (MSSA) involved burn wound infection. J. Drug Target. 23, 943\u2013952 (2015).","journal-title":"J. Drug Target."},{"key":"46119_CR49","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1007\/s00403-015-1566-y","volume":"307","author":"A G\u00fcrb\u00fcz","year":"2015","unstructured":"G\u00fcrb\u00fcz, A., \u00d6zhan, G., G\u00fcng\u00f6r, S. & Erdal, M. S. Colloidal carriers of isotretinoin for topical acne treatment: Skin uptake, ATR-FTIR and in vitro cytotoxicity studies. Arch. Dermatol. Res. 307, 607\u2013615 (2015).","journal-title":"Arch. Dermatol. Res."},{"key":"46119_CR50","doi-asserted-by":"publisher","first-page":"404","DOI":"10.2174\/1389200218666170306104042","volume":"18","author":"N Thotakura","year":"2017","unstructured":"Thotakura, N., Kumar, P., Wadhwa, S., Raza, K. & Katare, P. Dermatokinetics as an important tool to assess the bioavailability of drugs by topical nanocarriers. Curr. Drug Metab. 18, 404\u2013411 (2017).","journal-title":"Curr. Drug Metab."},{"key":"46119_CR51","doi-asserted-by":"crossref","unstructured":"Sharma, G., Dhankar, G., Thakur, K., Raza, K. & Katare, O. Benzyl benzoate-loaded microemulsion for topical applications: enhanced dermatokinetic profile and better delivery promises. AAPS PharmSciTech, 1\u201311, (2015).","DOI":"10.1208\/s12249-015-0464-0"},{"key":"46119_CR52","doi-asserted-by":"crossref","unstructured":"van Meerloo, J., Kaspers, G. J. L. & Cloos, J. In: IA. Cree (eds) Cancer Cell Culture: Methods and Protocols. (Humana Press, 2011). 237\u2013245.","DOI":"10.1007\/978-1-61779-080-5_20"},{"key":"46119_CR53","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/j.ijpharm.2006.12.045","volume":"337","author":"W Weyenberg","year":"2007","unstructured":"Weyenberg, W. et al. Cytotoxicity of submicron emulsions and solid lipid nanoparticles for dermal application. Int. J. Pharm. 337, 291\u2013298 (2007).","journal-title":"Int. J. Pharm."},{"key":"46119_CR54","unstructured":"ICH. ICH Guidance on Analytical Method Validation. Proceedings of the international Conference of Harmonization. (1996)."},{"key":"46119_CR55","doi-asserted-by":"publisher","first-page":"290","DOI":"10.3109\/08982104.2014.911314","volume":"24","author":"K Raza","year":"2014","unstructured":"Raza, K. et al. Lipid-based capsaicin-loaded nano-colloidal biocompatible topical carriers with enhanced analgesic potential and decreased dermal irritation. J. Liposome Res. 24, 290\u2013296 (2014).","journal-title":"J. Liposome Res."},{"key":"46119_CR56","doi-asserted-by":"publisher","first-page":"615","DOI":"10.2217\/nnm-2016-0405","volume":"12","author":"G Sharma","year":"2017","unstructured":"Sharma, G. et al. Aceclofenac cocrystal nanoliposomes for rheumatoid arthritis with better dermatokinetic attributes: A preclinical study. Nanomedicine (London, England) 12, 615\u2013638 (2017).","journal-title":"Nanomedicine (London, England)"},{"key":"46119_CR57","first-page":"3176391","volume":"2020","author":"K Singsai","year":"2020","unstructured":"Singsai, K. et al. Antilipoxygenase and anti-inflammatory activities of streblus asper leaf extract on xylene-induced ear edema in mice. Adv. Pharmacol. Pharm. Sci. 2020, 3176391 (2020).","journal-title":"Adv. Pharmacol. Pharm. Sci."},{"key":"46119_CR58","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.imr.2017.11.002","volume":"7","author":"HJ Mahdi","year":"2018","unstructured":"Mahdi, H. J., Khan, N. A. K., Asmawi, M. Z. B., Mahmud, R. & A\/L Murugaiyah, V. In vivo anti-arthritic and anti-nociceptive effects of ethanol extract of Moringa oleifera leaves on complete Freund\u2019s adjuvant (CFA)-induced arthritis in rats. Integr. Med. Res. 7, 85\u201394 (2018).","journal-title":"Integr. Med. Res."},{"key":"46119_CR59","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1080\/13880209.2016.1263869","volume":"55","author":"XF Shen","year":"2017","unstructured":"Shen, X. F. et al. The anti-arthritic activity of total glycosides from Pterocephalus hookeri, a traditional Tibetan herbal medicine. Pharm. Biol. 55, 560\u2013570 (2017).","journal-title":"Pharm. Biol."},{"key":"46119_CR60","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.tox.2008.03.016","volume":"248","author":"T Shen","year":"2008","unstructured":"Shen, T. et al. Trichloroethylene induced cutaneous irritation in BALB\/c hairless mice: Histopathological changes and oxidative damage. Toxicology 248, 113\u2013120 (2008).","journal-title":"Toxicology"},{"key":"46119_CR61","doi-asserted-by":"publisher","first-page":"190","DOI":"10.3109\/02652048.2010.546435","volume":"28","author":"K Raza","year":"2011","unstructured":"Raza, K. et al. Novel dithranol phospholipid microemulsion for topical application: Development, characterization and percutaneous absorption studies. J. Microencapsul. 28, 190\u2013199 (2011).","journal-title":"J. Microencapsul."},{"key":"46119_CR62","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.ijpharm.2010.12.036","volume":"406","author":"A Kovacevic","year":"2011","unstructured":"Kovacevic, A., Savic, S., Vuleta, G., M\u00fcller, R. H. & Keck, C. M. Polyhydroxy surfactants for the formulation of lipid nanoparticles (SLN and NLC): Effects on size, physical stability and particle matrix structure. Int. J. Pharm. 406, 163\u2013172 (2011).","journal-title":"Int. J. Pharm."},{"key":"46119_CR63","first-page":"924","volume":"4","author":"MB Zirak","year":"2015","unstructured":"Zirak, M. B. & Pezeshki, A. Effect of surfactant concentration on the particle size, stability and potential zeta of beta carotene nano lipid carrier. Int. J. Curr. Microbiol. App. Sci. 4, 924\u2013932 (2015).","journal-title":"Int. J. Curr. Microbiol. App. Sci."},{"key":"46119_CR64","doi-asserted-by":"publisher","first-page":"25741","DOI":"10.1021\/acsomega.2c03039","volume":"7","author":"DA Kuznetsova","year":"2022","unstructured":"Kuznetsova, D. A. et al. Enhancement of the transdermal delivery of nonsteroidal anti-inflammatory drugs using liposomes containing cationic surfactants. ACS Omega 7, 25741\u201325750 (2022).","journal-title":"ACS Omega"},{"key":"46119_CR65","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1016\/j.ejps.2009.04.008","volume":"37","author":"RK Subedi","year":"2009","unstructured":"Subedi, R. K., Kang, K. W. & Choi, H.-K. Preparation and characterization of solid lipid nanoparticles loaded with doxorubicin. Eur. J. Pharm. Sci. 37, 508\u2013513 (2009).","journal-title":"Eur. J. Pharm. Sci."},{"key":"46119_CR66","doi-asserted-by":"publisher","first-page":"1953","DOI":"10.2147\/IJN.S196771","volume":"14","author":"R Albash","year":"2019","unstructured":"Albash, R., Abdelbary, A. A., Refai, H. & El-Nabarawi, M. A. Use of transethosomes for enhancing the transdermal delivery of olmesartan medoxomil: In vitro, ex vivo, and in vivo evaluation. Int. J. Nanomed. 14, 1953\u20131968 (2019).","journal-title":"Int. J. Nanomed."},{"key":"46119_CR67","first-page":"435","volume":"11","author":"S Ghanbarzadeh","year":"2017","unstructured":"Ghanbarzadeh, S. et al. Dramatic improvement in dissolution rate of albendazole by a simple, one-step, industrially scalable technique. Res. Pharm. Sci. 11, 435\u2013444 (2017).","journal-title":"Res. Pharm. Sci."},{"key":"46119_CR68","doi-asserted-by":"publisher","first-page":"612","DOI":"10.4103\/0378-6323.72451","volume":"76","author":"OP Katare","year":"2010","unstructured":"Katare, O. P., Raza, K., Singh, B. & Dogra, S. Novel drug delivery systems in topical treatment of psoriasis: Rigors and vigors. Indian J. Dermatol. Venereol. Leprol. 76, 612\u2013621 (2010).","journal-title":"Indian J. Dermatol. Venereol. Leprol."},{"key":"46119_CR69","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1016\/j.ejpb.2004.09.006","volume":"59","author":"IA Alsarra","year":"2005","unstructured":"Alsarra, I. A., Bosela, A. A., Ahmed, S. M. & Mahrous, G. M. Proniosomes as a drug carrier for transdermal delivery of ketorolac. Eur. J. Pharm. Biopharm. 59, 485\u2013490 (2005).","journal-title":"Eur. J. Pharm. Biopharm."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-46119-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-46119-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-46119-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,5]],"date-time":"2024-11-05T16:35:33Z","timestamp":1730824533000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-46119-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,7]]},"references-count":69,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["46119"],"URL":"https:\/\/doi.org\/10.1038\/s41598-023-46119-7","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,12,7]]},"assertion":[{"value":"17 June 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 October 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 December 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"21681"}}